EVALUATION OF THE ANTIPYRETIC ACTIVITY OF HERBAL FORMULATIONS IN RAT MODEL OF LIPOPOLYSACCHARIDE (LPS)-INDUCED HYPERTHERMIA
1.0
TEST SYSTEM DETAILS:
Species : Rattus norvegicus (Rats)
Strain :
Sprague Dawley or Wistar
Age : 6-7
weeks
Sex : Male
No. of animals : 8/Group
Total animals : 56
2.0 TEST ARTICLES DETAILS
Tinospora cordifolia-based herbal formulation.
3.0
VEHICLE DETAILS
The test articles will be formulated
by utilizing 0.5% methylcellulose as the vehicle.
4.0
ALLOCATION OF GROUPS:
Group No. |
Group
Description |
Disease
Induction procedure |
Treatment
administered |
Dose
Volume and Route |
G1 |
Normal Control |
Normal saline administered by intraperitoneal route
(i.p.), Single injection |
0.5% MC, p.o., b.i.d. |
5 ml/kg, p.o. |
G2 |
Disease Control |
LPS (E. coli 0111: B4)- 100 µg/kg, i.p.-Single
injection |
0.5% MC, p.o., b.i.d. |
|
G3 |
Reference Control |
Paracetamol-250 mg/kg, p.o., b.i.d. |
||
G4 |
Treated with low dose |
LD:
5-15 mg/kg, b.i.d. |
||
G5 |
Treated with intermediate dose 1 |
ID-1: 15-50
mg/kg, b.i.d. |
||
G6 |
Treated with intermediate dose 2 |
ID-2: 50-150
mg/kg, b.i.d. |
||
G7 |
Treated with high dose |
HD: 150-500
mg/kg, b.i.d. |
Abbreviations: MC: Methylcellulose, p.o.-per os.,
i.p.-intraperitoneal bid: bis in die.
5.0
METHOD:
·
Healthy
animals will be selected for the study, randomized based on body weight and will
be assigned to 7 groups consisting of 8 animals each.
·
Animals
of the Group G1 will be designated as normal-control and administered 0.5% MC, p.o., b.i.d.
·
Disease
control animals (assigned to group G2) will receive 0.5% MC, p.o., b.i.d.
·
Animals
of group G3 will be treated with reference drug paracetamol at the dose of 250
mg/kg, p.o., b.i.d.
· Animals of group G4-G7 will be treated with HF, at different incremental dose levels as outlined in Section 4.0 of Annexure-I, twice daily.
·
Normal
control group (G1) will be administered a single injection of sterile normal
saline by intraperitoneal route, whereas animals allocated to groups G2 – G7 will be administered a single dose of LPS (100 µg/kg, i.p.) dissolved in
sterile normal saline.
·
Vehicle/Reference compound/Test compounds will be given orally on the
day of LPS-administration.
·
The rectal
temperature of animals will be measured once prior to LPS-administration and
then at 2, 4, 6, 12 and 24 hours post-LPS administration.
Additionally, the feed consumption of animals will be measured at 4, 6, 12 and
24 hours post-LPS administration and water intake of animals will be recorded
24 hours post-LPS administration.
·
For
estimation of the sickness behaviour in animals induced by hyperthermia, the
forced swim test and elevated plus maze test will be conducted 4 hours post-LPS
administration. For both the tests, the animals will be acclimatized to the
experimental apparatus 24 hours prior to LPS administration.
·
To conduct
the elevated plus maze test, animals will be placed at the centre of an
apparatus containing two open arms perpendicular to two closed arms in a plus
shape and a centre area. The time spent and number of entries of animals in
different arms will be recorded for 5 min. The
preference for being in open arms over closed arms will be calculated to
measure anxiety-like behavior. Further, to conduct the
forced swim test, animals will be placed in a cylinder of appropriate height
and diameter containing water at a temperature of 25 ± 1°C and forced to swim
for 5 min. The immobility time of the animals will be recorded and after
completion of the test session, the animals will be dried and returned to their
cages. An increase in the immobility time of the animals reflects
depression-like behaviour.
·
For the
estimation of pro-inflammatory markers, blood will be collected from the
retro-orbital plexus of anaesthetised rats at 6 hours post LPS administration.
After 24 hours of LPS administration, animals will be humanely sacrificed by an
overdose of Thiopentone sodium (150 mg/kg). After suitable anaesthesia, but
before the animal dies, blood will be collected from the retro-orbital plexus
and serum will be separated for the estimation of pro-inflammatory markers.
Immediately after the animal dies, the brain will be harvested, snap-frozen in
liquid nitrogen, and stored at -80°C until processed for molecular analysis.
6.0
PARAMETERS TO BE EVALUATED:
·
Rectal
temperature
·
Body weight
·
Feed and water
intake
·
Elevated plus
maze and Forced swim test
·
Serum
pro-inflammatory markers
·
qPCR analysis in
brain tissues for pro-inflammatory markers
7.0
REFERENCE(S):
1. Taksande,
B. G., Chopde, C. T., Umekar, M. J., & Kotagale, N. R. (2015). Agmatine
attenuates lipopolysaccharide-induced anorexia and sickness behavior in
rats. Pharmacology Biochemistry and Behavior, 132,
108-114.
2. Vijayakaran,
K., Kannan, K., Kesavan, M., Suresh, S., Sankar, P., Tandan, S. K., &
Sarkar, S. N. (2014). Arsenic reduces the antipyretic activity of paracetamol
in rats: modulation of brain COX-2 activity and CB1 receptor expression. Environmental
toxicology and pharmacology, 37(1), 438-447.
3. Wrotek, S., Jedrzejewski, T.,
Potera-Kram, E., & Kozak, W. (2011). Antipyretic activity of
N-acetylcysteine. Journal of Physiology and Pharmacology, 62(6),
669.
4. Jedrzejewski,
T., Piotrowski, J., Kowalczewska, M., Wrotek, S., & Kozak, W. (2015).
Polysaccharide peptide from Coriolus versicolor induces interleukin
6-related extension of endotoxin fever in rats. International Journal
of Hyperthermia, 31(6), 626-634.
1. List of All SOPs and Documents for the Microbiology Laboratory
2. List of All SOPs and Documents for In-vitro Laboratory
3. List of All SOPs and Documents for the In-vivo Laboratory.
4. List of All SOPs and Documents for Clinical Research
5. List of Instruments and Equipment Used In Laboratory Animal Facility
6. Animal Facility Design - Small Laboratory Animals (Rat, Mice, Rabbit, Guinea Pig)
7. List of Chemicals Needed for In-vivo Laboratory
8. List of Physiological Data for Small Laboratory Animals
9. Leading Lab-Diet Suppliers in India and Beyond
10. List of All SOPs and Documents for Animal House Facility
No comments:
Post a Comment